PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Cannulas: An overview PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • General cannula • Nasal cannula • Global nasal cannula market • Global general cannula market PART 07: Market segmentation by application • Cardiovascular surgery • General therapy • Oxygen therapy • Cosmetic surgery • Orthopedic surgery • Diabetes treatment • Ophthalmic surgery PART 08: Market segmentation by end-user • Hospitals • ASCs • Other medical facilities PART 09: Geographical segmentation • Cannulas market in Americas • Cannula market in EMEA • Cannula market in APAC PART 10: Buying criteria PART 11: Market drivers • Incidence of chronic diseases • Rise in surgical and MI procedures • Use of cannulas in heated humidified high-flow therapy • Demand for single-use cannulas PART 12: Impact of drivers PART 13: Market challenges • Pre- and post-procedure complications • Price wars among vendors • Market maturity PART 14: Impact of drivers and challenges PART 15: Market trends • Advances in technology for new injection molding • Improvisation in cannulas for safety and easy deployment • Safety cannulas help reduce needlestick injuries • Online marketing strategies PART 16: Vendor landscape • Competitive scenario PART 17: Key vendor analysis • Boston Scientific • Edward Lifesciences • MAQUET Holdings • Medtronic • Smith & Nephew • Terumo • Other prominent vendors PART 18: Appendix • List of abbreviations PART 19: Explore Technavio List of Exhibits Exhibit 01: Conversion rates for Euro (€) to US Dollar ($) 2013-2015 Exhibit 02: Product offerings Exhibit 03: Cannula color specification Exhibit 04: Cannulation procedure Exhibit 05: Classification of cannula Exhibit 06: US FDA classification of medical devices Exhibit 07: Clinical guidelines for cannulation Exhibit 08: Global cannulas market: Analysis of developed and emerging markets Exhibit 09: Global cannulas market 2015-2020 ($ billions) Exhibit 10: Global cannulas market: Opportunity analysis Exhibit 11: Five forces analysis Exhibit 12: Global cannula market segmentation by product 2015-2020 Exhibit 13: Global cannula market by product analysis 2015 Exhibit 14: Market growth lifecycle for general and nasal cannula 2015 Exhibit 15: Global nasal cannula market 2015-2020 ($ millions) Exhibit 16: Global general cannula market 2015-2020 ($ millions) Exhibit 17: Global cannulas market segmentation by product 2015-2020 ($ millions) Exhibit 18: Global cannulas market segmentation by product 2015-2020 Exhibit 19: Global cannulas market segmentation by application Exhibit 20: Longevity analysis of IV cannulae based on a prospective study conducted for IV cannula individuals Exhibit 21: Teflon versus steel cannula Exhibit 22: Segmentation of global cannula market by application type: Market insights 2015 and 2020 Exhibit 23: Global cannulas market segmentation by end-user 2015 Exhibit 24: Global cannulas market segmentation by geography 2015-2020 Exhibit 25: Global cannulas market segmentation by geography 2015-2020 ($ millions) Exhibit 26: Global cannulas market segmentation by geography 2015-2020 Exhibit 27: Global cannulas market: Growth and revenue analysis of various countries Exhibit 28: Global cannulas market: Geography lifecycle analysis 2015 Exhibit 29: Cannulas market in Americas 2015-2020 ($ millions) Exhibit 30: Cannulas market in EMEA 2015-2020 ($ millions) Exhibit 31: Cannulas market in APAC 2015-2020 ($ millions) Exhibit 32: Global cannulas market: Key buying criteria for flow diversion aneurysm treatment Exhibit 33: Impact of drivers Exhibit 34: Impact of drivers and challenges Exhibit 35: Boston Scientific: Cardiovascular segment 2013-2015 ($ billions) Exhibit 36: Boston Scientific: Metric analysis Exhibit 37: Edwards Lifesciences: Product segments Exhibit 38: Edward Lifesciences: Revenue of surgical heart valve therapy segment 2013-2015 ($ millions) Exhibit 39: Edward Lifesciences: Metric analysis Exhibit 40: Maquet: Metric analysis Exhibit 41: Medtronic: Business segments Exhibit 42: Medtronic: Metric analysis Exhibit 43: Smith & Nephew: Metric analysis Exhibit 44: Terumo: Revenue of cardiac and vascular segment 2013-2015 ($ billions) Exhibit 45: Terumo: Metric analysis Exhibit 46: Other prominent vendors

Boston Scientific, Edward Lifesciences, MAQUET Holdings, Medtronic, Smith & Nephew, Terumo, Ambler Surgical, Asico, Aspen Medical, B. Braun Melsungen, Bausch + Lomb, Becton, Dickinson and Company, Beacon Medical, Cannuflow, ConMed¸ DeVilbiss Healthcare, Fisher & Paykel Healthcare, Heyer Medical, Katalyst Surgical, Medin, Medline, Merz Aesthetics, Olympus, Salter Labs, Smiths Medical, Sorin, Sterimedix, Stryker, Wilson Ophthalmic.